Cargando…
Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer
Immune checkpoint inhibitors have significantly improved the prognosis in patients with non-small cell lung cancer, compared with cytotoxic agents. However, the prediction of treatment response is often difficult, even after assessing the tumor programmed death-ligand 1 expression. We conducted this...
Autores principales: | Inomata, Minehiko, Matsumoto, Masahiro, Takata, Naoki, Hayashi, Kana, Seto, Zenta, Hirai, Takahiro, Tokui, Kotaro, Taka, Chihiro, Okazawa, Seisuke, Kambara, Kenta, Imanishi, Shingo, Miwa, Toshiro, Hayashi, Ryuji, Matsui, Shoko, Tobe, Kazuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319808/ https://www.ncbi.nlm.nih.gov/pubmed/37402763 http://dx.doi.org/10.1038/s41598-023-37736-3 |
Ejemplares similares
-
Relationship between Patient Characteristics and the Timing of Provision of Explanation about DNAR to Patients with Advanced Lung Cancer
por: Inomata, Minehiko, et al.
Publicado: (2020) -
Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy
por: Inomata, Minehiko, et al.
Publicado: (2020) -
Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor‑infiltrating CD68‑positive cell counts in patients with EGFR‑mutant non‑small cell lung cancer
por: Tsuda, Takeshi, et al.
Publicado: (2023) -
SIRT1 and FOXO1 mRNA expression in PBMC correlates to physical activity in COPD patients
por: Taka, Chihiro, et al.
Publicado: (2017) -
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice
por: Inomata, Minehiko, et al.
Publicado: (2023)